Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Quarterly Earnings Insight

• Walgreens is expected to report an earnings per share (EPS) of $0.34, marking a 46% decline from the previous year.
• Revenue is projected to slightly increase by 0.9% to $36.66 billion.
• The company faces a potential buyout by Sycamore Partners, with shareholders offered $11.45 per share.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is a global leader in retail pharmacy, operating thousands of stores across the United States and Europe. The company provides a wide range of health and wellness products and services. However, it faces stiff competition from other major players like CVS Health and Rite Aid.

On June 26, 2025, Walgreens is set to release its quarterly earnings. Analysts expect an earnings per share (EPS) of $0.34, a significant 46% decline from the previous year. Despite this drop, revenue is projected to rise slightly by 0.9% to $36.66 billion, as highlighted by Seeking Alpha. This revenue growth, albeit modest, indicates some resilience in the company's sales performance.

The stability in EPS estimates over the past 30 days suggests that analysts have not adjusted their forecasts, which can influence investor behavior. Changes in these estimates often impact stock price movements, making them a key indicator for investors.

Walgreens is facing a potential buyout by Sycamore Partners due to declining profitability and substantial debt. Shareholders have been offered $11.45 per share, with a potential additional payout of $3 per share from future VillageMD asset sales. However, this additional payout is uncertain and carries significant risk, as the buyout deal is not yet finalized.

The company's financial metrics reveal challenges, with a high debt-to-equity ratio of 4.24, indicating a reliance on debt financing. The current ratio of 0.61 suggests potential liquidity issues, as it is below the standard threshold of 1. These factors contribute to a grim long-term outlook for Walgreens as a public company.